Protein-based oncopanel as addition to target sequencing in head and neck squamous cell carcinoma to individualize treatment decisions
- Sprache
-
Englisch
- Identifier
-
128013187X
Beteiligte Personen und Organisationen
von Witzleben, Adrian
Müller-Richter, Urs
Maurus, Katja
Brändlein, Stephanie
Theodoraki, Marie-Nicole
Brunner, Cornelia
Laban, Simon
Lennerz, Jochen
Möller, Peter
Hoffmann, Thomas K.
Döscher, Johannes
Schuler, Patrick J.
Müller-Richter, Urs
Maurus, Katja
Brändlein, Stephanie
Theodoraki, Marie-Nicole
Brunner, Cornelia
Laban, Simon
Lennerz, Jochen
Möller, Peter
Hoffmann, Thomas K.
Döscher, Johannes
Schuler, Patrick J.
- DOI
-
10.3390/ijms232415835
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
02.05.2023, 09:12 MESZ
Beteiligte
- von Witzleben, Adrian
- Müller-Richter, Urs
- Maurus, Katja
- Brändlein, Stephanie
- Theodoraki, Marie-Nicole
- Brunner, Cornelia
- Laban, Simon
- Lennerz, Jochen
- Möller, Peter
- Hoffmann, Thomas K.
- Döscher, Johannes
- Schuler, Patrick J.
Ähnliche Objekte (12)
Peripheral cytokine levels differ by HPV status and change treatment-dependently in patients with head and neck squamous cell carcinoma
Characterization and differentiation of the tumor microenvironment (TME) of orthotopic and subcutaneously grown head and neck squamous cell carcinoma (HNSCC) in immunocompetent mice
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemo- and immunotherapy
Increasing mean age of head and neck cancer patients at a German tertiary referral center
NF-κB and its role in checkpoint control
Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC)
Immune checkpoint expression in HNSCC patients before and after definitive chemoradiotherapy
Circulating exosomes inhibit B cell proliferation and activity
Peripheral cytokine levels differ by HPV status and change treatment-dependently in patients with head and neck squamous cell carcinoma
Patterns of tumor infiltrating lymphocytes in adenoid cystic carcinoma of the head and neck
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemoand immunotherapy
Clinical utility of a protein-based oncopanel in patients with end-stage head and neck cancer
Peripheral cytokine levels differ by HPV status and change treatment-dependently in patients with head and neck squamous cell carcinoma
Characterization and differentiation of the tumor microenvironment (TME) of orthotopic and subcutaneously grown head and neck squamous cell carcinoma (HNSCC) in immunocompetent mice
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemo- and immunotherapy
Increasing mean age of head and neck cancer patients at a German tertiary referral center
NF-κB and its role in checkpoint control
Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC)
Immune checkpoint expression in HNSCC patients before and after definitive chemoradiotherapy
Circulating exosomes inhibit B cell proliferation and activity
Peripheral cytokine levels differ by HPV status and change treatment-dependently in patients with head and neck squamous cell carcinoma
Patterns of tumor infiltrating lymphocytes in adenoid cystic carcinoma of the head and neck
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemoand immunotherapy
Clinical utility of a protein-based oncopanel in patients with end-stage head and neck cancer
Peripheral cytokine levels differ by HPV status and change treatment-dependently in patients with head and neck squamous cell carcinoma
Characterization and differentiation of the tumor microenvironment (TME) of orthotopic and subcutaneously grown head and neck squamous cell carcinoma (HNSCC) in immunocompetent mice
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemo- and immunotherapy
Increasing mean age of head and neck cancer patients at a German tertiary referral center
NF-κB and its role in checkpoint control
Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC)
Immune checkpoint expression in HNSCC patients before and after definitive chemoradiotherapy
Circulating exosomes inhibit B cell proliferation and activity
Peripheral cytokine levels differ by HPV status and change treatment-dependently in patients with head and neck squamous cell carcinoma
Patterns of tumor infiltrating lymphocytes in adenoid cystic carcinoma of the head and neck
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemoand immunotherapy